1. Home
  2. USFD vs RPRX Comparison

USFD vs RPRX Comparison

Compare USFD & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo US Foods Holding Corp.

USFD

US Foods Holding Corp.

HOLD

Current Price

$75.32

Market Cap

17.1B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$39.70

Market Cap

16.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USFD
RPRX
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
16.2B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
USFD
RPRX
Price
$75.32
$39.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$88.36
$46.00
AVG Volume (30 Days)
2.2M
4.3M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
2.21%
EPS Growth
2.09
N/A
EPS
2.38
1.75
Revenue
$39,115,000,000.00
$2,349,844,000.00
Revenue This Year
$6.60
$37.13
Revenue Next Year
$6.05
$1.48
P/E Ratio
$31.54
$22.68
Revenue Growth
4.80
3.70
52 Week Low
$57.36
$24.05
52 Week High
$85.11
$41.24

Technical Indicators

Market Signals
Indicator
USFD
RPRX
Relative Strength Index (RSI) 50.83 57.50
Support Level $69.88 $39.24
Resistance Level $79.13 $40.50
Average True Range (ATR) 1.59 0.91
MACD 0.29 -0.08
Stochastic Oscillator 57.05 76.02

Price Performance

Historical Comparison
USFD
RPRX

About USFD US Foods Holding Corp.

US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: